CN

News Center / NEWS

News Center

Announcement on the maturity of some bank wealth management products

2020-04-28 11:33

Stock code: 002675 Stock abbreviation: Dongcheng Pharmaceutical Announcement number: 2014-031

 

The company and all members of the board of directors guarantee the truthfulness, accuracy and completeness of the information disclosed, and there are no false records, misleading statements or major omissions.

 

Yantai Dongcheng Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") and Xiamen International Bank Co., Ltd. Fuzhou Branch (hereinafter referred to as "Xiamen International") signed the "Flying Wealth Management RMB" on April 11, 2014. Win the "Structured Deposit Product Contract", using RMB 80 million to develop structured deposit business in Xiamen International, the name of the wealth management product is "Flying Wealth Management RMB "Profit and Win-Win" Structured Deposit Product" 14545, and the product term is 2014 From April 11, 2014 to June 19, 2014, the annual interest rate was 5.5%; for the details of the above, please refer to the "About the Use of Partial Idle" published on www.cninfo.com.cn on April 15, 2014. "Announcement on Raising Funds to Purchase Wealth Management Products" (Announcement No.: 2014-009) and the company's designated information disclosure media "Securities Daily", "Securities Times", "China Securities News" and "Shanghai Securities News". The principal and income of the above-mentioned wealth management products were received on June 19, 2014. The company has recovered all the principal and income, and obtained a total of 843,333.33 yuan of income from wealth management investment. Special announcement!

 

Yantai Dongcheng Pharmaceutical Group Co., Ltd. Board of Directors

June 21, 2014

HOT RELATED NEWS

HOT RELATED NEWS
Tel:86-0535-6391521\6391522
Email:zxu@dcb-group.com
Add:No.7 ChangBaiShan Road, Yantai Development Zone, ShanDong, China
About Us
Company Profile
Chairman Address
Honors of Dongcheng
Evolutional History
Development Strategy
Corporate Culture
Subsidiaries
Contact Us
News
Group News
Media Coverage
Products
API Series
Preparation Series
Nuclide Drug Series
Health Care Business
R&D
Technology Platform
Honors and Qualifications
Advanced Equipment
HR
Talent Concepts
Talent Development
Talent Recruitment
Jobs
IR
Instant Quotes
Regular Reports
Investor Services
Responsibility
Social Welfare
Safety & Environmental Protection
Occupational Health
COPYRIGHT 2020 Yantai Dongcheng Pharmaceutical Group Co., Ltd. All rights reserved 魯ICP備18035060號-1